chr1-11794614-C-A
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_005957.5(MTHFR):c.1167-76G>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.242 in 1,607,144 control chromosomes in the GnomAD database, including 48,787 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.21 ( 3722 hom., cov: 32)
Exomes 𝑓: 0.24 ( 45065 hom. )
Consequence
MTHFR
NM_005957.5 intron
NM_005957.5 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.137
Genes affected
MTHFR (HGNC:7436): (methylenetetrahydrofolate reductase) The protein encoded by this gene catalyzes the conversion of 5,10-methylenetetrahydrofolate to 5-methyltetrahydrofolate, a co-substrate for homocysteine remethylation to methionine. Genetic variation in this gene influences susceptibility to occlusive vascular disease, neural tube defects, colon cancer and acute leukemia, and mutations in this gene are associated with methylenetetrahydrofolate reductase deficiency.[provided by RefSeq, Oct 2009]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.78).
BP6
Variant 1-11794614-C-A is Benign according to our data. Variant chr1-11794614-C-A is described in ClinVar as [Likely_benign]. Clinvar id is 1177041.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-11794614-C-A is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.323 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.213 AC: 32419AN: 151922Hom.: 3726 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
32419
AN:
151922
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.245 AC: 356202AN: 1455104Hom.: 45065 Cov.: 34 AF XY: 0.249 AC XY: 180016AN XY: 724260 show subpopulations
GnomAD4 exome
AF:
AC:
356202
AN:
1455104
Hom.:
Cov.:
34
AF XY:
AC XY:
180016
AN XY:
724260
Gnomad4 AFR exome
AF:
AC:
4460
AN:
33354
Gnomad4 AMR exome
AF:
AC:
5906
AN:
44712
Gnomad4 ASJ exome
AF:
AC:
5880
AN:
26082
Gnomad4 EAS exome
AF:
AC:
7694
AN:
39632
Gnomad4 SAS exome
AF:
AC:
29694
AN:
86028
Gnomad4 FIN exome
AF:
AC:
14475
AN:
53170
Gnomad4 NFE exome
AF:
AC:
272017
AN:
1106204
Gnomad4 Remaining exome
AF:
AC:
14612
AN:
60164
Heterozygous variant carriers
0
15929
31858
47787
63716
79645
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
9130
18260
27390
36520
45650
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.213 AC: 32433AN: 152040Hom.: 3722 Cov.: 32 AF XY: 0.215 AC XY: 15992AN XY: 74294 show subpopulations
GnomAD4 genome
AF:
AC:
32433
AN:
152040
Hom.:
Cov.:
32
AF XY:
AC XY:
15992
AN XY:
74294
Gnomad4 AFR
AF:
AC:
0.143522
AN:
0.143522
Gnomad4 AMR
AF:
AC:
0.156172
AN:
0.156172
Gnomad4 ASJ
AF:
AC:
0.22549
AN:
0.22549
Gnomad4 EAS
AF:
AC:
0.207734
AN:
0.207734
Gnomad4 SAS
AF:
AC:
0.336997
AN:
0.336997
Gnomad4 FIN
AF:
AC:
0.28662
AN:
0.28662
Gnomad4 NFE
AF:
AC:
0.248609
AN:
0.248609
Gnomad4 OTH
AF:
AC:
0.216114
AN:
0.216114
Heterozygous variant carriers
0
1292
2584
3876
5168
6460
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
374
748
1122
1496
1870
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
893
AN:
3478
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:2
-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
not provided Benign:2
Jul 07, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Homocystinuria due to methylene tetrahydrofolate reductase deficiency Benign:1
Jul 01, 2021
Genome-Nilou Lab
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Mutation Taster
=100/0
polymorphism (auto)
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at